Open AccessResponse evaluation of chemotherapy in metastatic colorectal cancer by contrast enhanced ultrasound
Author(s) -
Ramin Schirin-Sokhan,
Ron Winograd,
Christoph Roderburg,
J Bubenzer,
Nicole Cabral do Ó,
Dorothee Guggenberger,
Hartmut Hecker,
Christian Trautwein,
Jens J. W. Tischendorf
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i6.541
Subject(s) - medicine , bevacizumab , colorectal cancer , contrast enhanced ultrasound , chemotherapy , radiology , oncology , ultrasound , progressive disease , stage (stratigraphy) , cetuximab , cancer , paleontology , biology
To evaluate whether contrast enhanced ultrasound (CEUS) might also be used for response prediction and early response evaluation in patients receiving bevacizumab based chemotherapy for metastasized colorectal cancer.